Figure 6. Inhibitor of κB-α (IκB-α) protein (A) and inhibitor of κB-β (IκB-β) protein (B) in muscle lysates from placebo (n = 7), RSV (n = 9), exercise-trained (T) and placebo (n = 13) and exercise-trained and RSV-supplemented subjects (n = 14) before (Pre) and after (Post) 8 weeks of intervention.

Protein content is normalized to GAPDH and given in arbitrary units (a.u.). Representative blots are shown in each panel, with samples loaded in the same order as depicted in the graph. Values are presented as means ± SEM. *Significantly different from Pre within treatment, P < 0.05.